Categories: Life SciencesSoftware

Insiders buying QHR Technologies

A recent report from MarketResearch.com said the U.S. EMR market is expected to grow from $2.17-billion in 2009 to more than $6-billion in 2015; an estimated compound annual growth rate of 18.1%

Since 2008, Kelowna-based QHR Technologies (TSXV:QHR) has grown from just $6.52-million in revenue to a $23.86 million topline in fiscal 2011.

Those merely watching the company’s stock chart, however, might be hard pressed to see a difference. Shares of QHR have remained at approximately the same level for nearly three years.

Recent filings show certain management members believe this is an untenable disconnect; QHR insiders have begun to buy the company’s stock in the open market.

On June 15th and 20th, QHR CFO Jerry Diener picked up 16,000 shares at an average price of $.59 cents. Company Chairman Ernest Wigmore bought 27,500 shares at $.57 on June 20th, then another 172,500 shares at $.60 cents later that day.

QHR Technologies has become an aggressive consolidator in the Canadian electronic medical records space. The recently announced pickup of Vancouver-based Open EC Technologies was the company’s twelfth acquisition in the past nine years. QHR’s success mirrors larger trends: a recent report from MarketResearch.com said the U.S. EMR market is expected to grow from $2.17-billion in 2009 to more than $6-billion in 2015; an estimated compound annual growth rate of 18.1%

At press time, share of QHR Technologies were even at $.56 cents

________________________________

_________________________________

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: qhr
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

2 hours ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

12 hours ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

14 hours ago

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

1 day ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

2 days ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

2 days ago